XML 26 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities    
Net income (loss) $ 384,611 $ (51,703)
Adjustments to reconcile net income (loss) to net cash from (used in) operating activities:    
Depreciation and amortization 85,226 33,931
Impairment of assets 16,257 6,942
Change in fair value of assets held for sale 0 2,582
Realized (gain) loss on financial instruments 5,756 4,215
Unrealized (gain) loss on financial instruments (664,993) 0
Other (income) expense 0 1,724
(Gain) loss on disposal of property, plant and equipment 13 (833)
Foreign exchange loss (gain) 2,201 (1,190)
Stock-based compensation expense 72,405 8,184
Amortization of debt issuance costs 1,340 0
Changes in assets and liabilities:    
Accounts receivable and other receivables (13,090) (11,115)
Other assets 169 (154)
Financial asset, current 0 6,530
Tax related receivables 2,581 0
Tax related liabilities 187,943 1,322
Accounts payable and accrued expenses 3,489 45,029
Other liabilities 48,679 2,380
Deferred revenue 22,457 (209)
Prepayments and deposits (12,647) (52,468)
Operating lease liabilities (44) 918
Net cash from (used in) operating activities 142,353 (3,915)
Investing activities    
Payments for property, plant and equipment net of computer hardware prepayments (180,307) (105,831)
Payments for computer hardware prepayments (100,304) (277,558)
Payments for other prepayments and other assets (266) (4,257)
Proceeds from disposal of property, plant and equipment 0 509
Net cash from (used in) investing activities (280,877) (387,137)
Financing activities    
Payment of offering costs for the issuance of Ordinary shares - at-the-market offering (18,495) (102)
Proceeds from loan funded shares 557 816
Proceeds from exercise of options 6,597 0
Payment of borrowing transaction costs (877) 0
Proceeds from the issuance of Ordinary shares – at-the-market offering 618,355 83,955
Net cash from (used in) financing activities 606,137 84,669
Net increase (decrease) in cash and cash equivalents 467,613 (306,383)
Cash and cash equivalents at the beginning of the period 564,526 404,601
Effects of exchange rate changes on cash and cash equivalents 124 371
Cash and cash equivalents at the end of period 1,032,263 98,589
Supplemental cash flow information:    
Cash paid for interest 0 (17)
Cash paid for income taxes 0 0
Supplemental schedule of non-cash investing and financing activities:    
Additions to right of use assets in exchange for an operating lease liability 0 954
Unrealized gain (loss) on derivative asset 195,210 0
Unrealized gain (loss) on financial asset 664,993 0
Realized gain (loss) on financial instruments (5,756) (4,215)
Reclassification of property, plant and equipment to assets held for sale 0 13,648
Restricted stock units    
Supplemental schedule of non-cash investing and financing activities:    
Issuance of common stock - restricted stock unit settlements 1,787 4,758
Not designated as hedging instrument    
Adjustments to reconcile net income (loss) to net cash from (used in) operating activities:    
Realized (gain) loss on financial instruments 5,756 0
Supplemental schedule of non-cash investing and financing activities:    
Realized gain (loss) on financial instruments (5,756) 0
Prepaid forward contract    
Adjustments to reconcile net income (loss) to net cash from (used in) operating activities:    
Unrealized (gain) loss on financial instruments (469,783) 0
Supplemental schedule of non-cash investing and financing activities:    
Unrealized gain (loss) on financial asset $ 469,783 $ 0